Westlake Therapeutics

The row entry ''Westlake Therapeutics'' paired with URL ''westlakebio.com'' represents a data-source inconsistency requiring correction. Westlake Village BioPartners is a prominent U.S. biotechnology-sector venture capital firm based in Westlake Village, California (suburb of Los Angeles in Ventura County / western Los Angeles County area). The firm was founded in 2018 by Co-Founders Beth Seidenberg M.D. (prior General Partner at Kleiner Perkins Caufield & Byers for 13+ years, where she led the firm's life-sciences practice) and Sean Harper M.D. (prior Head of R&D at Amgen). Westlake Village BioPartners invests in biotechnology, life-sciences, drug-discovery, and medical-innovation companies aEUR" typically from the concept / founding stage through Series A and B. The firm has raised multiple institutional funds (Westlake Fund I in 2018 at USD 320 million, Westlake Fund II in 2020 at USD 500 million, Westlake Fund III in 2024 at approximately USD 450 million+) with aggregate AUM exceeding USD 1.2 billion+ across vintages. ''Westlake Therapeutics'' is not the same entity as Westlake Village BioPartners aEUR" it may refer to a portfolio company or be a data-source mis-entry. The actual firm at westlakebio.com is the VC, not a therapeutics operating company, and should be reclassified accordingly.